Arthur M. Cohen & Associates’s Pfizer PFE Stock Holding History

Arthur M. Cohen & Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,900	Closed	-$200K	–	136
2022 Q4	$200K	Buy	+3,900	New	+$187K	0.05%	123
2022 Q3	–	Sell	-3,900	Closed	-$204K	–	134
2022 Q2	$204K	Hold	3,900	–	–	0.05%	125
2022 Q1	$202K	Hold	3,900	–	–	0.04%	135
2021 Q4	$231K	Buy	+3,900	New	+$193K	0.04%	135
2020 Q4	–	Sell	-6,956	Closed	-$242K	–	149
2020 Q3	$242K	Hold	6,956	–	–	0.06%	125
2020 Q2	$216K	Hold	6,956	–	–	0.07%	115
2020 Q1	$210K	Hold	6,956	–	–	0.08%	105
2019 Q4	$259K	Sell	6,956 -844	-11%	-$30.1K	0.08%	108
2019 Q3	$266K	Buy	7,800 +482	+7%	+$17.5K	0.07%	108
2019 Q2	$301K	Sell	7,318 -474	-6%	-$18.8K	0.1%	95
2019 Q1	$314K	Hold	7,792	–	–	0.11%	92
2018 Q4	$322K	Buy	7,792 +474	+6%	+$19.7K	0.1%	91
2018 Q3	$306K	Sell	7,318 -300	-4%	-$11.5K	0.09%	101
2018 Q2	$262K	Buy	7,618 +300	+4%	+$10.3K	0.1%	97
2018 Q1	$243K	Sell	7,318 -474	-6%	-$16.3K	0.09%	97
2017 Q4	$322K	Buy	+7,792	New	+$266K	0.09%	89
2017 Q2	$367K	Sell	11,462 -2,414	-17%	-$76.1K	0.14%	80
2017 Q1	$350K	Sell	13,876 -5,902	-30%	-$186K	0.16%	77
2016 Q4	$610K	Buy	+19,778	New	+$604K	0.32%	49
2014 Q3	$312K	Buy	+9,215	New	+$259K	0.15%	89

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arthur M. Cohen & Associates's PFE Position: Q1 2023 in Review

Arthur M. Cohen & Associates sold out of Pfizer (PFE) in Q1 2023, closing a stake of 3,900 shares — an estimated $200K sold.

Arthur M. Cohen & Associates first reported a position in PFE in Q3 2014 and held it in 20 quarters. The position peaked at $610K in Q4 2016. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Arthur M. Cohen & Associates reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Arthur M. Cohen & Associates sold 3,900 Pfizer shares in Q1 2023, an estimated $200K.
Arthur M. Cohen & Associates first reported a position in Pfizer in Q3 2014 and held it in 20 quarters.
Arthur M. Cohen & Associates's Pfizer position peaked at $610K in Q4 2016.
3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2023, filed 24 Apr 2023.